US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Drugs Made In America Acquisition Corp

10.43

-0.0200-0.19%

Volume:2.81K

Turnover:29.30K

Market Cap:349.58M

PE:48.57

High:10.45

Open:10.45

Low:10.43

Close:10.45

52wk High:10.45

52wk Low:9.95

Shares:33.52M

Float Shares:23.41M

Volume Ratio:1.49

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2148

EPS(LYR):-0.0560

ROE:--

ROA:--

PB:1.55

PE(LYR):-186.36

Loading ...

Overview Company News Filings

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Correspondence

Form CORRESP - Correspondence

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DMAA/filings"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"DMAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","market":"US","secType":"STK","nameCN":"Drugs Made In America Acquisition Corp","latestPrice":10.43,"timestamp":1770757200000,"preClose":10.45,"halted":0,"volume":2806,"delay":0,"changeRate":-0.0019138755980860837,"floatShares":23405912,"shares":33517143,"eps":0.21475,"marketStatus":"Pre-Mkt","change":-0.02,"latestTime":"02-11 09:19:05 EST","open":10.45,"high":10.45,"low":10.43,"amount":29298.6569,"amplitude":0.001914,"askPrice":12.62,"askSize":100,"bidPrice":10.42,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.21475,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":10.45,"postHourTrading":{"tag":"盘后","latestPrice":10.43,"preClose":10.43,"latestTime":"16:04 EST","volume":1,"amount":10.45,"timestamp":1770757445941,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4935064617094644},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","floatShares":23405912,"roa":"--","roe":"--","lyrEps":-0.055968,"volumeRatio":1.4935064617094644,"shares":33517143,"dividePrice":0,"high":10.45,"amplitude":0.001914,"preClose":10.45,"low":10.43,"week52Low":9.95,"pbRate":"1.55","week52High":10.45,"institutionHeld":0,"latestPrice":10.43,"committee":0.818182,"eps":0.21475,"divideRate":0,"volume":2806,"delay":0,"ttmEps":0.21475,"open":10.45,"prevYearClose":10.3742,"prevWeekClose":10.44,"prevMonthClose":10.43,"prevQuarterClose":10.3742,"fiveDayClose":10.42,"twentyDayClose":10.38,"sixtyDayClose":10.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMAA\",params:#limit:5,,,undefined,":[{"date":"2025-11-18","symbol":"DMAA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763499600000,"name":null,"time":"Post Market","dateTimestamp":1763442000000,"actualEps":null},{"market":"US","date":"2025-08-14","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-20","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747713600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-03-31","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMAA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMAA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMAA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMAA","date":"2026-02-10","current":48.568102,"percent":1,"low":-5272.922078,"twenty":-717.524833,"median":-706.346256,"eighty":63.542057,"high":64.29265,"avg":-564.005713,"sd":513.702478,"marketCap":350254144},"quantilePoints":[{"date":"2025-01-10","current":-608.075079,"twenty":-608.075079,"median":-608.075079,"eighty":-608.075079,"marketCap":291714290},{"date":"2025-01-24","current":-5272.922078,"twenty":-1541.044479,"median":-608.075079,"eighty":-608.075079,"marketCap":2529600000},{"date":"2025-01-31","current":-425.873505,"twenty":-1541.044479,"median":-608.075079,"eighty":-425.745934,"marketCap":204306000},{"date":"2025-02-07","current":-426.936594,"twenty":-608.075079,"median":-426.511358,"eighty":-426.043599,"marketCap":204816000},{"date":"2025-02-14","current":-428.637537,"twenty":-608.075079,"median":-427.4894,"eighty":-426.086123,"marketCap":205632000},{"date":"2025-02-21","current":-429.488008,"twenty":-608.075079,"median":-428.127254,"eighty":-426.213694,"marketCap":206040000},{"date":"2025-02-28","current":-695.318062,"twenty":-642.693308,"median":-428.637537,"eighty":-426.426311,"marketCap":333567715},{"date":"2025-03-07","current":-697.410294,"twenty":-694.899616,"median":-429.062772,"eighty":-426.511358,"marketCap":334571430},{"date":"2025-03-14","current":-696.712883,"twenty":-696.294437,"median":-608.075079,"eighty":-426.7665,"marketCap":334236858},{"date":"2025-03-21","current":-698.805113,"twenty":-697.410294,"median":-608.075079,"eighty":-426.936594,"marketCap":335240572},{"date":"2025-03-28","current":-700.199934,"twenty":-697.689258,"median":-694.620652,"eighty":-427.446877,"marketCap":335909715},{"date":"2025-04-04","current":-700.058307,"twenty":-699.084077,"median":-694.969357,"eighty":-427.94015,"marketCap":335841772},{"date":"2025-04-11","current":-700.756969,"twenty":-700.114958,"median":-695.666767,"eighty":-428.144263,"marketCap":336176944},{"date":"2025-04-17","current":-700.756969,"twenty":-700.534155,"median":-696.712883,"eighty":-428.217404,"marketCap":336176944},{"date":"2025-04-25","current":-702.852952,"twenty":-700.756969,"median":-697.061588,"eighty":-428.39005,"marketCap":337182458},{"date":"2025-05-02","current":-704.250274,"twenty":-701.315898,"median":-697.410294,"eighty":-428.637537,"marketCap":337852801},{"date":"2025-05-09","current":-706.346256,"twenty":-702.154292,"median":-697.758998,"eighty":-428.637537,"marketCap":338858315},{"date":"2025-05-16","current":-706.695588,"twenty":-703.691345,"median":-698.805113,"eighty":-428.977725,"marketCap":339025901},{"date":"2025-05-23","current":-707.743579,"twenty":-704.948934,"median":-699.780416,"eighty":-429.743149,"marketCap":339528658},{"date":"2025-05-30","current":-708.09291,"twenty":-705.647596,"median":-700.058307,"eighty":-465.715705,"marketCap":339696244},{"date":"2025-06-06","current":-709.839561,"twenty":-706.346256,"median":-700.199934,"eighty":-608.075079,"marketCap":340534172},{"date":"2025-06-13","current":-710.538223,"twenty":-706.975053,"median":-700.756969,"eighty":-608.075079,"marketCap":340869344},{"date":"2025-06-20","current":-711.935546,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341539687},{"date":"2025-06-27","current":-711.236883,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341204515},{"date":"2025-07-03","current":-711.935546,"twenty":-708.861436,"median":-701.106301,"eighty":-677.311537,"marketCap":341539687},{"date":"2025-07-11","current":-713.332868,"twenty":-709.979293,"median":-701.738587,"eighty":-694.620652,"marketCap":342210030},{"date":"2025-07-18","current":-714.730188,"twenty":-710.95742,"median":-702.154292,"eighty":-694.620652,"marketCap":342880372},{"date":"2025-07-25","current":-716.826172,"twenty":-711.236883,"median":-702.852952,"eighty":-694.620652,"marketCap":343885887},{"date":"2025-08-01","current":-717.524833,"twenty":-711.935546,"median":-704.250274,"eighty":-695.17858,"marketCap":344221058},{"date":"2025-08-08","current":-717.524833,"twenty":-712.005412,"median":-704.948934,"eighty":-695.318062,"marketCap":344221058},{"date":"2025-08-15","current":-718.223495,"twenty":-713.332868,"median":-705.647596,"eighty":-695.597026,"marketCap":344556230},{"date":"2025-08-22","current":-717.524833,"twenty":-714.17126,"median":-706.342764,"eighty":-695.945732,"marketCap":344221058},{"date":"2025-08-29","current":-716.365056,"twenty":-714.86992,"median":-706.346256,"eighty":-696.573401,"marketCap":343664674},{"date":"2025-09-05","current":-716.826172,"twenty":-716.222528,"median":-706.695588,"eighty":-696.712883,"marketCap":343885887},{"date":"2025-09-12","current":-716.12751,"twenty":-716.48802,"median":-707.044919,"eighty":-696.712883,"marketCap":343550715},{"date":"2025-09-19","current":-718.223495,"twenty":-716.826172,"median":-707.743579,"eighty":-697.13133,"marketCap":344556230},{"date":"2025-09-26","current":-718.132667,"twenty":-716.826172,"median":-707.743579,"eighty":-697.410294,"marketCap":344512657},{"date":"2025-10-03","current":-717.524833,"twenty":-716.826172,"median":-708.09291,"eighty":-697.410294,"marketCap":344221058},{"date":"2025-10-10","current":-718.223495,"twenty":-717.52064,"median":-708.966236,"eighty":-697.410294,"marketCap":344556230},{"date":"2025-10-17","current":-720.319477,"twenty":-717.524833,"median":-709.839561,"eighty":-697.410294,"marketCap":345561744},{"date":"2025-10-24","current":-720.668808,"twenty":-717.524833,"median":-710.538223,"eighty":-697.828739,"marketCap":345729330},{"date":"2025-10-31","current":-721.018137,"twenty":-717.524833,"median":-710.887554,"eighty":-698.526149,"marketCap":345896915},{"date":"2025-11-07","current":-720.494143,"twenty":-717.524833,"median":-711.236883,"eighty":-698.805113,"marketCap":345645537},{"date":"2025-11-14","current":-721.018137,"twenty":-718.219302,"median":-711.236883,"eighty":-698.805113,"marketCap":345896915},{"date":"2025-11-21","current":63.492837,"twenty":-718.223495,"median":-711.236883,"eighty":-698.805113,"marketCap":345896915},{"date":"2025-11-28","current":63.554362,"twenty":-718.223495,"median":-711.236883,"eighty":-697.410294,"marketCap":346232087},{"date":"2025-12-05","current":63.554362,"twenty":-718.2207,"median":-711.236883,"eighty":-696.991847,"marketCap":346232087},{"date":"2025-12-12","current":63.738934,"twenty":-718.182971,"median":-710.538223,"eighty":-695.806249,"marketCap":347237601},{"date":"2025-12-19","current":63.738934,"twenty":-717.889533,"median":-709.839561,"eighty":-694.620652,"marketCap":347237601},{"date":"2025-12-26","current":63.800458,"twenty":-717.524833,"median":-709.839561,"eighty":-625.384194,"marketCap":347572772},{"date":"2026-01-02","current":63.826298,"twenty":-717.524833,"median":-708.79157,"eighty":-608.075079,"marketCap":347713544},{"date":"2026-01-09","current":63.861982,"twenty":-717.524833,"median":-707.918244,"eighty":-428.637537,"marketCap":347907944},{"date":"2026-01-16","current":63.98503,"twenty":-717.524833,"median":-707.743579,"eighty":-428.042207,"marketCap":348578287},{"date":"2026-01-23","current":64.231126,"twenty":-717.524833,"median":-707.743579,"eighty":-426.851547,"marketCap":349918972},{"date":"2026-01-30","current":64.231126,"twenty":-717.524833,"median":-707.044919,"eighty":-426.086123,"marketCap":349918972},{"date":"2026-02-06","current":64.169602,"twenty":-717.524833,"median":-706.695588,"eighty":-327.489953,"marketCap":349583801},{"date":"2026-02-10","current":64.29265,"twenty":-717.524833,"median":-706.346256,"eighty":63.542057,"marketCap":350254144}],"updateTime":1770819545547},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMAA\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20426984","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112096-DMAA","pdf_url":"","pub_time":1763499965000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMAA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-112096-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025112096/ea0264976-10q_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0264976-10q_drugs.htm","type":"10-Q","id":"NTFILE4Sgy3PuuxyWD9WZG","market":"us","size":824555},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025112096/ea026497601ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea026497601ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILEEHvfDoHheCMSJNc7","market":"us","size":14722},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025112096/ea026497601ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea026497601ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILEDpeVP5Z89ZW1KoUN","market":"us","size":14656},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025112096/ea026497601ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea026497601ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILE57LwbHxMHbyxPq2e","market":"us","size":6544},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025112096/ea026497601ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea026497601ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILE8jU3tE4do25mw6Zx","market":"us","size":6478}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-11-19 05:06","pubTimestamp":1763499965,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20426970","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025111704-DMAA","pdf_url":"","pub_time":1763431415000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-111704-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025111704/ea0265998-8k_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0265998-8k_drugs.htm","type":"8-K","id":"NTFILE4Mvs6YoMFaZeB2Cj","market":"us","size":46824}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-11-18 10:03","pubTimestamp":1763431415,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19991186","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025076681-DMAA","pdf_url":"","pub_time":1755202629000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMAA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-076681-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea0252999-10q_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0252999-10q_drugs.htm","type":"10-Q","id":"NTFILE9VqQs8ujH3MQWkVR","market":"us","size":492913},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILE6JZrGYDxPPVc5yUT","market":"us","size":12554},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE3aMe4cD57MDFBNCN","market":"us","size":12567},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILEGqAqZXg3MJzBBX1G","market":"us","size":4957},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILEDDBD119ydaXRjGgz","market":"us","size":4971}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-08-15 04:17","pubTimestamp":1755202629,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19673672","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025046061-DMAA","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMAA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/0001213900-25-046061-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea0242665-10q_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0242665-10q_drugs.htm","type":"10-Q","id":"NTFILE6VGcRZzQufj8nfND","market":"us","size":392808},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILECeQwy4Fg4gRE4tyc","market":"us","size":10509},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE7SZGwipQUkJSvtsj","market":"us","size":10510},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILE135Rg4XrTnHJjxPS","market":"us","size":4357},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILE4Z3WPDuNTJJTkXSY","market":"us","size":4386}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19326644","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025026240-DMAA","pdf_url":"","pub_time":1743393600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"DMAA","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/0001213900-25-026240-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea0235148-10k_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0235148-10k_drugs.htm","type":"10-K","id":"NTFILEJ45aWmEve9yWSSvX","market":"us","size":512508},{"description":"DESCRIPTION OF THE COMPANY'S SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex4-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex4-5_drugs.htm","type":"EX-4.5","id":"NTFILE7bhg4KXK1nWhY5NJ","market":"us","size":70479},{"description":"INSIDER TRADING POLICY","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex19_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex19_drugs.htm","type":"EX-19","id":"NTFILEHUQfkS6yTyp7qZJ2","market":"us","size":42475},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILE288ZV7gFeJPDgqDM","market":"us","size":9041},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE4fD3wF7f93g4S8kN","market":"us","size":9074},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILEBzFkjU6zGvMBKWJP","market":"us","size":3385},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILEHhqjKmbwsrfbSvhF","market":"us","size":3376},{"description":"CLAWBACK POLICY","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex97-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex97-1_drugs.htm","type":"EX-97.1","id":"NTFILE5ZPWfEoRpeSL8eqT","market":"us","size":23287}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2025-03-31 12:00","pubTimestamp":1743393600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167493","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025016702-DMAA","pdf_url":"","pub_time":1740442536000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-016702-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED FEBRUARY 18, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea023193601ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea023193601ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHT4KKAZexViN9c2o","market":"us","size":58923},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea0231936-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0231936-8k_drugs.htm","type":"8-K","id":"NTFILEHqYY8fFSq22REHEj","market":"us","size":20445}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-02-25 08:15","pubTimestamp":1740442536,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167258","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025016602-DMAA","pdf_url":"","pub_time":1740430753000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-016602-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED FEBRUARY 20, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea023198001ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea023198001ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE55TDDeFLokDqaKG5","market":"us","size":7834},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea0231980-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0231980-8k_drugs.htm","type":"8-K","id":"NTFILE95fk92JMAGcREX11","market":"us","size":18833}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-02-25 04:59","pubTimestamp":1740430753,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20137982","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025010079-DMAA","pdf_url":"","pub_time":1738645200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/0001213900-25-010079-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED JANUARY 29, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea022985301ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022985301ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE4htaeCQuRb8r1ZJz","market":"us","size":137733},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea0229853-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229853-8k_drugs.htm","type":"8-K","id":"NTFILEDUAEZUjL2a8iU5dt","market":"us","size":33315}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-02-04 13:00","pubTimestamp":1738645200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19184969","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025008377-DMAA","pdf_url":"","pub_time":1738213200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED JANUARY 27, 2025, BY AND BETWEEN THE COMPANY AND C","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex1-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022913501ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE7DEwTSwzD79pnfFo","market":"us","size":244779},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229135-8k_drugs.htm","type":"8-K","id":"NTFILECR9prfXuF4WriPBY","market":"us","size":37390},{"description":"SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILE6y5nBqer6m5VjPCK","market":"us","size":341912},{"description":"RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND BETWEEN THE COMPANY AND VSTOCK T","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEHqQwyw5r8dDBqd4N","market":"us","size":68171},{"description":"LETTER AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY, DRUGS MADE IN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEB7izsf1QakzE59FV","market":"us","size":46260},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE C","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILE5SWxaFfCpRrB7cKr","market":"us","size":104109},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY A","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEByrWWRBFs3zEaVR2","market":"us","size":103717},{"description":"AMENDED AND RESTATED PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED JANUARY 27, 202","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILEDA84c9fHpiVdduTH","market":"us","size":25588},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILE6yFhnAew6RYaeFiu","market":"us","size":81921},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF JANUARY 7, 2025, BY AND BETWEEN T","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILEBpzu9uWtjycodYdV","market":"us","size":10843},{"description":"NOTE CONVERSION AGREEMENT, DATED AS OF JANUARY 29, 2025, BY AND BETWEEN THE COMP","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILEGY6RwEcRaqFUmDo2","market":"us","size":19862},{"description":"PROMISSORY NOTE, DATED AS OF JANUARY 29, 2025, ISSUED TO DRUGS MADE IN AMERICA A","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILEHnoaKrMyHQskVsmP","market":"us","size":26140},{"description":"PRESS RELEASE DATED JANUARY 27, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHE6FFjRfS4z5b9kq","market":"us","size":8449},{"description":"PRESS RELEASE DATED JANUARY 29, 2025","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILE3JGbm8bRhiMxNaNN","market":"us","size":7942},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILE8nS9kL6Z2gvh6x3D","market":"us","size":17938},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEsEB1K5xMUjyL7FwT","market":"us","size":7532}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-01-30 13:00","pubTimestamp":1738213200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20138243","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005828-DMAA","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/0001213900-25-005828-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8dodEiJeAWxXnH3y","market":"us","size":7176}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20138119","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005825-DMAA","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/0001213900-25-005825-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8gPfv6MMCdeeWpuu","market":"us","size":10176}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19019096","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025001208-DMAA","pdf_url":"","pub_time":1736139600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/0001213900-25-001208-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea0209546-10.htm","primary":true,"translateUrl":"","linkName":"ea0209546-10.htm","type":"S-1/A","id":"NTFILE5gaSz7tH2HwxepV8","market":"us","size":141681},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea020954610ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954610ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE2XTHxskw6GrTVt8L","market":"us","size":2505}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2025-01-06 13:00","pubTimestamp":1736139600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20139072","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025000704-DMAA","pdf_url":"","pub_time":1735880400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/0001213900-25-000704-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9NPW8oRFC73iLRkp","market":"us","size":9232}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-01-03 13:00","pubTimestamp":1735880400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18922271","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024106894-DMAA","pdf_url":"","pub_time":1733720400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/0001213900-24-106894-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea0209546-08.htm","primary":true,"translateUrl":"","linkName":"ea0209546-08.htm","type":"S-1/A","id":"NTFILE75vGQNkNyZDPkjVc","market":"us","size":4566963},{"description":"AMENDED AND RESTATED PROMISSORY NOTE, DATED AS OF DECEMBER 5, 2024, ISSUED TO DR","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea020954608ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954608ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILE2sDgmMASBET1KMMr","market":"us","size":24466}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-12-09 13:00","pubTimestamp":1733720400,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18872196","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024102238-DMAA","pdf_url":"","pub_time":1732510800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/0001213900-24-102238-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea0209546-07.htm","primary":true,"translateUrl":"","linkName":"ea0209546-07.htm","type":"S-1/A","id":"NTFILEBm3a5cuan3h8VRhA","market":"us","size":4578563},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILEz9nXdd3A6wjv5Ae2","market":"us","size":242042},{"description":"AMENDMENT TO PROMISSORY NOTE, DATED NOVEMBER 21, 2024, ISSUED TO DRUGS MADE IN A","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex10-9_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex10-9_drugs.htm","type":"EX-10.9","id":"NTFILE6cZcvDAUGuhGv1dE","market":"us","size":10461},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE84AZvh46wZthGVis","market":"us","size":2138}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-11-25 13:00","pubTimestamp":1732510800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18805908","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024095138-DMAA","pdf_url":"","pub_time":1730955600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/0001213900-24-095138-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea0209546-06.htm","primary":true,"translateUrl":"","linkName":"ea0209546-06.htm","type":"S-1/A","id":"NTFILEGdWGRmCavHS5KFhv","market":"us","size":4384963},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILE52CqPnGysN62kcvR","market":"us","size":267372},{"description":"SPECIMEN UNIT CERTIFICATE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEF4Pn74v7TBq4iqjj","market":"us","size":19628},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILEH3LeBGruKc6CxeFr","market":"us","size":17389},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILEBWg2pSm52NCX3wCn","market":"us","size":69956},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILEAUKqhsfbrY2rkbpF","market":"us","size":41444},{"description":"OPINION OF LOEB & LOEB LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILEJ1TGCHonbWfQ5hxP","market":"us","size":11240},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILExjQmyedNYNiykkcB","market":"us","size":55274},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILE7YGvJfRU75YGJBar","market":"us","size":101759},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILECbZRwPK3Rd7dWCDt","market":"us","size":100105},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILE9f8r4nCgkmaCCCgu","market":"us","size":23889},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEGKtqDTzHTA3yMprw","market":"us","size":1490},{"description":"FILING FEE TABLE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILEEdG5QXe9qdJTLmAb","market":"us","size":17953},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE1L9RiS3qixRhApyn","market":"us","size":11039},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEHbRNkfrQp1tWCNjf","market":"us","size":12611},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILE4DdCFJjwRTcBGpwL","market":"us","size":4190}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-11-07 13:00","pubTimestamp":1730955600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18655309","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024082386-DMAA","pdf_url":"","pub_time":1727409600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/0001213900-24-082386-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea0209546-04.htm","primary":true,"translateUrl":"","linkName":"ea0209546-04.htm","type":"S-1/A","id":"NTFILEbcBNoigA7EHHGszu","market":"us","size":4370093},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE6bDGdMN5j8gLzAvt","market":"us","size":255602},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILEFUCimmFp1bMVQrxV","market":"us","size":267362},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEDgy3e4H1JMudeimH","market":"us","size":19918},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILEBiL65WEDucAdYcrx","market":"us","size":17378},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILEGASzErrMw1svD4LH","market":"us","size":69275},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILESeJT2GWtcM6yS5FP","market":"us","size":38746},{"description":"OPINION OF LOEB & LOEB LLP","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILE9buuXKMWWf8TjA3c","market":"us","size":11258},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEHLt2V1ZbZRkPm9Pm","market":"us","size":56331},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILE3ZTGw4Bq7fTB7erN","market":"us","size":103298},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILEHZbLkpyEJ9zZ9Rdv","market":"us","size":98804},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILECHhq4hM6j47a3Zfa","market":"us","size":23878},{"description":"FORM OF INDEMNITY AGREEMENT","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILE5MP2XKGhCs5BpPjB","market":"us","size":95570},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILEKPutbfsAZCAgF1F4","market":"us","size":14688},{"description":"FORM OF CODE OF CONDUCT","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex14_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex14_drugs.htm","type":"EX-14","id":"NTFILEEHpA6kEueodwtwwH","market":"us","size":48800},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE4jJaH9sfA1BnB4xM","market":"us","size":3959},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-4_drugs.htm","type":"EX-99.4","id":"NTFILEHRM4u9B8h8GGDNdi","market":"us","size":38309},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-5_drugs.htm","type":"EX-99.5","id":"NTFILEDLtrLYoQseaUcVJ2","market":"us","size":31713},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEEjTYtD9kG3im3Acb","market":"us","size":4190},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEHxTfSTkKCk2vAHZp","market":"us","size":11039},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE3Xy4HXa7ahw9ZvG1","market":"us","size":12611}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-09-27 12:00","pubTimestamp":1727409600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18591895","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076546-DMAA","pdf_url":"","pub_time":1725654597000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-24-076546-index.html","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea0209546-02.htm","primary":true,"translateUrl":"","linkName":"ea0209546-02.htm","type":"S-1/A","id":"NTFILEAH1xB9ooMsoDUf92","market":"us","size":4364625},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea020954602ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954602ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE8NypJrEjxYdqaZT4","market":"us","size":2499}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-09-07 04:29","pubTimestamp":1725654597,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18655310","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024064074-DMAA","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMAA","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/0001213900-24-064074-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea0209546-01.htm","primary":true,"translateUrl":"","linkName":"ea0209546-01.htm","type":"S-1","id":"NTFILEA6w1erH74trA3SbS","market":"us","size":4342212},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILEC3BK41cp5D19L3KX","market":"us","size":242396},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-2_drugs.htm","type":"EX-3.2","id":"NTFILE6nyNFQT3NwYYP8RT","market":"us","size":211632},{"description":"PROMISSORY NOTE, DATED JUNE 14, 2024, ISSUED TO DRUGS MADE IN AMERICA ACQUISITIO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEBPRrQuF6QGAbckwe","market":"us","size":19191},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED JUNE 14, 2024, BETWEEN THE REGISTRANT A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILE3onGt9FpjpPMHXYy","market":"us","size":45339},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEAg5THzHSiQDx45KC","market":"us","size":3678},{"description":"CONSENT OF CATHERINE DO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHpe5P9QqmQoNrvGq","market":"us","size":1993},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILEEpXJroHBTNqtiBYT","market":"us","size":2022},{"description":"CONSENT OF MYRON W. SHULGAN","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-3_drugs.htm","type":"EX-99.3","id":"NTFILE5MZGrip4qeRSPwd4","market":"us","size":2019},{"description":"FILING FEE TABLE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILEBpkQ6t631a4vpB7f","market":"us","size":17530}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}